Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01097096
Show Display Options
Download search resultsDownload the search results for:
NCT01097096 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Condition: Alzheimer's Disease
Intervention: Biological: CAD106

Indicates status has not been verified in more than two years